Parkinson's disease (PD) is the most common age associated neurodegenerative disease, which has been extensively studied for its etiology and phenotype. PD has been widely studied in alternate model system such as rodents towards understanding the role of neurotoxin by inducing PD. This study is aimed to understand the biomechanism of PD in zebrafish model system induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The phenotype and role of various genes and proteins for Parkinsonism were tested and evaluated in this study using behaviour, molecular and proteomic approaches. Zebrafish PD model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine showed a significant level of decrease in the movement with erratic swimming pattern and increased freezing bouts. CHCHD2, EEF2B, LRRK2, PARK7, PARK2, POLG, SNCGB and SYNB genes were differentially regulated at the transcript level in PD zebrafish. Similarly a total of 73 proteins were recognized as differentially expressed in the nervous system of zebrafish due to Parkinsonism based on quantitative proteomics approach. Proteins such as NEFL,MUNC13-1, NAV2 and GAPVD1 were down regulated in the zebrafish brain for the PD phenotype, which were associated with the neurological pathways. This zebrafish based PD model can be used as a potential model system for screening prospective drug molecules for PD.
Results Results
 Western blot expression analysis of the PD markers, SNCA, PARK8, DJ1 and tyrosine hydroxylase protein.
The expression levels of the proteins were calculated based on band quantification analysis using Image J software. Protein expression was shown at a basal level of 1 fold and statistical significance was estimated as the mean ± SEM. *p < 0.05 vs. control group (one-way ANOVA post test, N = 2).  Numbers of crosses were found significantly recovered in M1 group for both 1 and 2-dose of deprenyl. Similarly 2-dose deprenyl showed significant reduction in number of freezing bouts and freezing duration in M1 PD. The recovery of PD phenotype in M2 was found mildly and non-significantly retrieved upon deprenyl treatment.  mRNA expression analysis confirms the Parkinsonism in the MPTP treated zebrafish with up regulation of a group of molecular markers such as CHCHD2, CRF, DNM2A, EIF4G1, SNCGA, SNCGB, SNCB, etc.
 The model of PD in zebrafish has not only established an alternate model for the PD but a potential model for screening drug targets for an effective treatment against the disease. The markers established in this study associated for the disease can be used as biomarkers for the disease and as screening targets for potential PD drugs.
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